All news by author: Health Reporter

The five-year study explored if the drug sold under the brand names Wegovy, Ozempic and Rybelsus could reduce the risk of heart attacks or stroke in obese people without diabetes. It comprised 17,604 adults over the age of 45 from 41 countries

Patients could benefit from additional support and monitoring in the years following diagnosis, researchers said after it emerged that heart attack survivors are at risk of further serious health conditions